RE:RE:RE:Stock PriceWhen we have days like this it always feel strange. Because it is not based on any actual information or changes in the underlying asset (the company). I've hated saying it but it feels manipulated sometimes. I just don't see a large group of investors deciding to exit NOW and at these price points when the clinical data is good and they still have a number of months of cash left from the last PP. I can see some gunshy people rushing to sell when they see this happening because in the past it is usually a prelude to an announcement about another PP. I personally feel that RDW has to know that the PP well is dry. He needs to make a suboptimal deal with someone (sell the potential GBM rights for all of Japan or Turkey or something like that) and get cash that way. A terrible deal gets you cash to start GBM is still a really good deal compared to nothing progressing. Regional licensing deals are common in biotech and should be doable
On another note:
I wonder if the big push on PR in the past week is partly to great more of a web presence for TLT so that anyone that they are working with sees that they really do exist.